MedWatch

Analyst: Demant's guidance reflects improved market conditions

Demant exceeded Sydbank's analyst Søren Løntoft Hansen's performance forecast, when the Danish hearing aid firm laid out its guidance for the 2021 fiscal year Tuesday morning.

Photo: Sydbank/PR

On Tuesday morning hearing aid firm Demant presented its forecast for the new fiscal year in connection with the company's 2020 annual financial report.

The new guidance for earnings before interests, taxes, depreciations and amortizations set at DKK 2.85-3.15bn (USD 463.8-512.6m) and an organic growth rate of 23-27 percent shows great promise, according to Søren Løntoft Hansen, Senior Equity Analyst at Danish bank Sydbank.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs